P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model

Detalles Bibliográficos
Autores principales: Bauer, C, Sterzik, A, Bauernfeind, F, Duewell, P, Conrad, C, Kiefl, R, Endres, S, Eigler, A, Schnurr, M, Dauer, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072447/
http://dx.doi.org/10.1186/2051-1426-2-S2-P1
_version_ 1782322962604490752
author Bauer, C
Sterzik, A
Bauernfeind, F
Duewell, P
Conrad, C
Kiefl, R
Endres, S
Eigler, A
Schnurr, M
Dauer, M
author_facet Bauer, C
Sterzik, A
Bauernfeind, F
Duewell, P
Conrad, C
Kiefl, R
Endres, S
Eigler, A
Schnurr, M
Dauer, M
author_sort Bauer, C
collection PubMed
description
format Online
Article
Text
id pubmed-4072447
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40724472014-06-27 P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model Bauer, C Sterzik, A Bauernfeind, F Duewell, P Conrad, C Kiefl, R Endres, S Eigler, A Schnurr, M Dauer, M J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072447/ http://dx.doi.org/10.1186/2051-1426-2-S2-P1 Text en Copyright © 2014 Bauer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Bauer, C
Sterzik, A
Bauernfeind, F
Duewell, P
Conrad, C
Kiefl, R
Endres, S
Eigler, A
Schnurr, M
Dauer, M
P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
title P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
title_full P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
title_fullStr P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
title_full_unstemmed P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
title_short P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
title_sort p10. concomitant gemcitabine therapy negatively affects dc vaccine-induced cd8+ t cell and b cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072447/
http://dx.doi.org/10.1186/2051-1426-2-S2-P1
work_keys_str_mv AT bauerc p10concomitantgemcitabinetherapynegativelyaffectsdcvaccineinducedcd8tcellandbcellresponsesbutimprovesclinicalefficacyinamurinepancreaticcarcinomamodel
AT sterzika p10concomitantgemcitabinetherapynegativelyaffectsdcvaccineinducedcd8tcellandbcellresponsesbutimprovesclinicalefficacyinamurinepancreaticcarcinomamodel
AT bauernfeindf p10concomitantgemcitabinetherapynegativelyaffectsdcvaccineinducedcd8tcellandbcellresponsesbutimprovesclinicalefficacyinamurinepancreaticcarcinomamodel
AT duewellp p10concomitantgemcitabinetherapynegativelyaffectsdcvaccineinducedcd8tcellandbcellresponsesbutimprovesclinicalefficacyinamurinepancreaticcarcinomamodel
AT conradc p10concomitantgemcitabinetherapynegativelyaffectsdcvaccineinducedcd8tcellandbcellresponsesbutimprovesclinicalefficacyinamurinepancreaticcarcinomamodel
AT kieflr p10concomitantgemcitabinetherapynegativelyaffectsdcvaccineinducedcd8tcellandbcellresponsesbutimprovesclinicalefficacyinamurinepancreaticcarcinomamodel
AT endress p10concomitantgemcitabinetherapynegativelyaffectsdcvaccineinducedcd8tcellandbcellresponsesbutimprovesclinicalefficacyinamurinepancreaticcarcinomamodel
AT eiglera p10concomitantgemcitabinetherapynegativelyaffectsdcvaccineinducedcd8tcellandbcellresponsesbutimprovesclinicalefficacyinamurinepancreaticcarcinomamodel
AT schnurrm p10concomitantgemcitabinetherapynegativelyaffectsdcvaccineinducedcd8tcellandbcellresponsesbutimprovesclinicalefficacyinamurinepancreaticcarcinomamodel
AT dauerm p10concomitantgemcitabinetherapynegativelyaffectsdcvaccineinducedcd8tcellandbcellresponsesbutimprovesclinicalefficacyinamurinepancreaticcarcinomamodel

Ejemplares similares